 INDIANAPOLIS and NEW YORK, Dec. 15, 2020 PRNewswire -- Eli Lilly and Company NYSE: LLY and Prevail Therapeutics Inc. NASDAQ: PRVL today announced a definitive agreement for Lilly to acquire Prevail for 22.50 per share in cash or an aggregate of approximately 880 million payable... 